Crosstex International, Inc., a subsidiary of Cantel Medical Corp., announces the recent issuance of patents covering its Sure-Check® Sterilization Pouch in Canada, Australia and New Zealand.
The claims granted under these patents broadly cover the unique features of the Sure-Check pouches, which provide Class 4 multi-variable indicator technology. Canadian Patent Number 2721772 was issued on Oct. 2, 2012; New Zealand Patent Number 587238 was issued on Oct. 8, 2012 and Australian Patent Number 2009205559 was issued on Dec. 13, 2012. Additionally, Crosstex has corresponding patent applications pending in the United States, Europe and China.
Andrew Whitehead, Crosstexs senior vice president of sales and business development, says, Our intellectual property in this critical area of infection control protocols continues to grow and we are delighted that it is being recognized. We view the issuance of these patents to be essential in the protection of the significant investments in R&D that Crosstex has made to bring the latest infection control products to market. We are vigilant about maintaining our industry leadership position in this area and are also focused on broadening our intellectual property estate to further protect and enhance the value of our product pipeline.
Source: Cantel Medical Corp.